ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2026)
ENDRA Life Sciences (NDRA) reported Cash from Investing Activities of $450000.0 for Q1 2026, up 2704.17% year-over-year from $16047.5 in Q1 2025, and up 115.0% quarter-over-quarter from -$3.0 million in Q4 2025.
ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 10 years of Cash from Investing Activities data on file, last reported at $450000.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $450000.0, up 2704.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 40505.1% YoY), and the FY2025 annual result was -$3.0 million, down 23479.87% from the prior year.
- Cash from Investing Activities improved to $450000.0 in Q1 2026 per NDRA's latest filing, from -$3.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $450000.0 in Q1 2026 and troughed at -$3.0 million in Q4 2025.
- A 5-year average of -$255215.8 and a median of -$23796.0 in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities plunged 98.56% in 2022, then soared 2704.17% in 2026.
- A 5-year view of Cash from Investing Activities shows it stood at -$38563.0 in 2022, then jumped by 105.91% to $2279.0 in 2023, then soared by 382.67% to $11000.0 in 2024, then slumped by 27372.73% to -$3.0 million in 2025, then soared by 115.0% to $450000.0 in 2026.
- Business Quant data shows NDRA's Cash from Investing Activities at $450000.0 in Q1 2026, -$3.0 million in Q4 2025, and -$17280.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -31.35 Mn |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | 450,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 450,000.00 |
| Mar 31, 2026 | 450,000.00 |
| Dec 31, 2025 | -3.00 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -17,280.00 |
| Mar 31, 2025 | -17,280.00 |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | -23,796.00 |
| Mar 31, 2024 | -23,796.00 |
| Dec 31, 2023 | 2,279.00 |
| Dec 31, 2023 | 2,279.00 |
| Mar 31, 2023 | -27,000.00 |
| Mar 31, 2023 | -27,000.00 |
| Dec 31, 2022 | -38,563.00 |
| Dec 31, 2022 | -38,563.00 |
| Sep 30, 2022 | -14,861.00 |
| Sep 30, 2022 | -14,861.00 |
| Jun 30, 2022 | -59,800.00 |
| Jun 30, 2022 | -59,800.00 |